The US Food and Drug Administration (FDA) has approved expanded MRI labeling for Abbott's Proclaim dorsal root ganglion (DRG) neurostimulator system in patients with complex regional pain syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback